Pharmacotherapy for postural tachycardia syndrome
Postural tachycardia syndrome (POTS) is a disorder characterized by the presence of orthostatic symptoms (including lightheadedness, palpitations, nausea, dyspnea, and tremulousness) as well as excessive upright tachycardia. POTS predominantly affects women of childbearing age. Treating POTS involves a multi-faceted approach using non-pharmacological and pharmacological interventions. There are no pharmacological treatments that are currently United States Food and Drug Administration (FDA) approved for POTS due to lack of randomized controlled trials.
Source: Autonomic Neuroscience: Basic and Clinical - Category: Neuroscience Authors: Amanda J. Miller, Satish R. Raj Tags: Review Source Type: research
More News: Brain | Food and Drug Administration (FDA) | Neurology | Neuroscience | USA Health | Women